Q702 for the Treatment of Patients With Hematologic Malignancies
Mayo Clinic
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Dartmouth-Hitchcock Medical Center
Karyopharm Therapeutics Inc
Scripps Health
Thomas Jefferson University
Northwestern University
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
University College, London
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
National Cancer Institute (NCI)
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Cellerant Therapeutics